40 deaths from Sudan cholera outbreak in 1 week, says MSF – DW – 08/15/2025
Cholera is spreading rapidly in Sudan's Darfur region, killing 40 people over the past week alone, medical charity Doctors Without Borders (MSF) said in a report.
MSF teams have treated over 2,300 cholera patients during the last seven days, according to the charity. It blamed the rapid spread of the life-threatening diarrhoeal disease on water shortages and a collapsed health care system, which have left communities vulnerable amid an ongoing civil war in Sudan.
Fighting between the Sudanese military, its allies, and rival paramilitary group Rapid Support Forces (RSF) has killed more than 40,000 people, displaced as many as 12 million, caused disease outbreaks and pushed many to the brink of famine.
Darfur Governor Mini Arko Minawi told DW that the outbreak was largely concentrated in areas under RSF occupation.
"Those suffering from cholera are located outside the government's service areas, with most of them living in areas controlled by the so-called RSF which have taken over these areas but are unable to provide services there," Minawi said. "These forces and their commanders have no knowledge how to provide services or how to govern."
Around 100,000 cases have been reported since July 2024, according to the World Health Organization (WHO), which describes cholera as a "disease of poverty," because it spreads where there is poor sanitation and a lack of clean water.
"Poor access to water, the destruction of health centers and hospitals, a considerable weakening of the population's health, and a decline in the immune systems is making people vulnerable to cholera," said Jacky Mamou, president of the Collectif Urgence Darfour, a French advocacy coalition that raise awareness about the humanitarian crisis in Sudan.
Sudan's civil war has also led to massive population displacements into camps that are struggling to accommodate them.
According to Rodrigue Alitanou from the Alliance for International Medical Action (ALIMA), a humanitarian medical NGO, diseases are spreading due to poor hygiene, difficulties in accessing drinking water, and overcrowding, as hundreds of thousands of people are gathered together in small geographical areas.
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
MSF said it has treated over 2,300 patients and recorded 40 deaths in the past week alone. The medical charity said that women, children, and the elderly were most at risk.
In Tawila, a town in Sudan's North Darfur state, MSF reported an especially extreme situation with the disease. Some 380,000 have fled the ongoing fighting around the state's besieged capital, El-Fasher.
Fighting in Sudan between the army and the paramilitary RSF has been ongoing since April 2023, creating one of the world's worst humanitarian crises.
"We must facilitate the supply of necessities for hospitals to function, facilitate the arrival of humanitarian aid, but also facilitate the work of humanitarian workers in the country," said Alitanou.
UNICEF has reported that more than 640,000 children under the age of 5 are now at risk of disease in North Darfur alone, where fighting continues between the Sudanese army and paramilitaries for control of El-Fasher.To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
DW
3 days ago
- DW
40 deaths from Sudan cholera outbreak in 1 week, says MSF – DW – 08/15/2025
A unprecedented cholera outbreak in Sudan has killed 40 people in one week, says MSF. Civil war is worsening the crisis by cutting off water, healthcare, and humanitarian aid access. Cholera is spreading rapidly in Sudan's Darfur region, killing 40 people over the past week alone, medical charity Doctors Without Borders (MSF) said in a report. MSF teams have treated over 2,300 cholera patients during the last seven days, according to the charity. It blamed the rapid spread of the life-threatening diarrhoeal disease on water shortages and a collapsed health care system, which have left communities vulnerable amid an ongoing civil war in Sudan. Fighting between the Sudanese military, its allies, and rival paramilitary group Rapid Support Forces (RSF) has killed more than 40,000 people, displaced as many as 12 million, caused disease outbreaks and pushed many to the brink of famine. Darfur Governor Mini Arko Minawi told DW that the outbreak was largely concentrated in areas under RSF occupation. "Those suffering from cholera are located outside the government's service areas, with most of them living in areas controlled by the so-called RSF which have taken over these areas but are unable to provide services there," Minawi said. "These forces and their commanders have no knowledge how to provide services or how to govern." Around 100,000 cases have been reported since July 2024, according to the World Health Organization (WHO), which describes cholera as a "disease of poverty," because it spreads where there is poor sanitation and a lack of clean water. "Poor access to water, the destruction of health centers and hospitals, a considerable weakening of the population's health, and a decline in the immune systems is making people vulnerable to cholera," said Jacky Mamou, president of the Collectif Urgence Darfour, a French advocacy coalition that raise awareness about the humanitarian crisis in Sudan. Sudan's civil war has also led to massive population displacements into camps that are struggling to accommodate them. According to Rodrigue Alitanou from the Alliance for International Medical Action (ALIMA), a humanitarian medical NGO, diseases are spreading due to poor hygiene, difficulties in accessing drinking water, and overcrowding, as hundreds of thousands of people are gathered together in small geographical areas. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video MSF said it has treated over 2,300 patients and recorded 40 deaths in the past week alone. The medical charity said that women, children, and the elderly were most at risk. In Tawila, a town in Sudan's North Darfur state, MSF reported an especially extreme situation with the disease. Some 380,000 have fled the ongoing fighting around the state's besieged capital, El-Fasher. Fighting in Sudan between the army and the paramilitary RSF has been ongoing since April 2023, creating one of the world's worst humanitarian crises. "We must facilitate the supply of necessities for hospitals to function, facilitate the arrival of humanitarian aid, but also facilitate the work of humanitarian workers in the country," said Alitanou. UNICEF has reported that more than 640,000 children under the age of 5 are now at risk of disease in North Darfur alone, where fighting continues between the Sudanese army and paramilitaries for control of view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
DW
3 days ago
- DW
Trouble sleeping? Here's how to fall asleep quickly – DW – 08/15/2025
Hot weather can make it hard to get a good night's rest. But there are scientifically proven methods to fall asleep quickly. One in three adults report some sort of insomnia and around half of those say it disrupts their functioning during the day. It only gets worse in summer. Heatwaves substantially disrupt sleep quality — studies show that even short heatwaves lasting one or two days can reduce sleep duration by more than an hour each night. Heat reduces sleep quality and duration by interfering with the body's natural cooling process, which is crucial for initiating and maintaining sleep. That's why keeping your bedroom cool during the day with shades and fans can do wonders for sleep quality. That, and having a dark and quiet environment to sleep in. But what other tips are there for getting to sleep on hot nights? There is robust scientific evidence that exercise improves sleep quality and duration, particularly for those with sleep disorders. On average, adults who exercise for at least 30 minutes a day sleep an average of 15 minutes longer than those who do not. Unsurprisingly, daily exercise tires the body out. But how does it help with sleep? Studies show physical activity can better sleep in a variety of ways. It increases the production of melatonin, a hormone that regulates sleep-wake cycles. This helps you fall asleep more quickly. Exercise also reduces stress, which is a common factor which makes falling and staying asleep more difficult. That's why exercise is recommended as one of several treatments for people with sleep disorders. Studies have shown that moderate-intensity aerobic exercise improves sleep among patients with insomnia. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video You still have half of the caffeine in your system 6-8 hours after you consume it. That's why drinking coffee in the afternoon or evening can reduce the duration of sleep by around 45 minutes, according to one meta-analysis. To avoid reductions in total sleep time, the researchers of that analysis recommended consuming coffee no later than 8.8 hours before bedtime. Another big culprit of sleep disturbances is screen use before sleep. One study found an hour of screen use in bed increases your risk of insomnia by 59% and lowers sleep duration by an average of 24 minutes per night. The study is part of growing evidence showing that phone or laptop use before bed negative affects sleep habits. There's a common belief blue light emitted from screens tricks the body into thinking it's time to wake up. But this isn't quite right. Glasses or apps that block blue light on your phone or laptop don't necessarily improve sleep — what's more effective is turning down the brightness or reducing screen time. And even better than that is to reduce screen time before bed. Instead, try reading a book. Studies show reading in bed does improve sleep quality. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Some people recommend the "4-7-8" breathing method, based on ancient yogic breathing exercises developed by Andrew Weil, a US-based 'celebrity doctor', as an effective technique. This requires you to place the tip of your tongue against the ridge behind your upper teeth, exhale completely, then inhale through your nose for four counts. Then hold your breath for seven counts and exhale slowly through the mouth for eight counts. Advocates say this breathing method can calm a person down in just a few cycles, helping bring about sleep quicker, especially when anxious or stressed. But does the evidence really say it works? A small number of low-quality studies do suggest positive effects like improved heart rate and blood pressure regulation, and reduced anxiety. However, there is little scientific research to back this up, or verify its long-term benefits. In particular, claims that the technique is a "natural tranquilizer for the nervous system," as Weil suggests, are unverified. Nevertheless, there is plenty of anecdotal evidence that the 4-7-8 breathing method helps people fall asleep. And there's likely no harm, aside from a little light headedness, so it may be worth a try.
DW
4 days ago
- DW
Why US budget cuts could derail future mRNA vaccine progress – DW – 08/14/2025
US Government cuts to mRNA vaccine research could set technological advances, reduce access to therapies, and raise their costs. mRNA vaccines are credited with helping to end the COVID-19 pandemic and save millions of lives. Since then, researchers have been developing the technology to prevent a variety of infectious diseases and cancer. But experts warn this progress has been severely impacted after US health secretary Robert F Kennedy announced cuts to mRNA technology research. In total, the US health department will cancel contracts and withdraw $500 million (€427 million) of research funding, it announced on August 8. The announcement was the latest in a series of anti-science policies brought in by President Trump's second term in office, including apolitical take-over of federal research grants and withdrawing from the World Health Organization. What does this mean for the future of mRNA vaccine development? We take a look. mRNA vaccines were first tested in mice to vaccinate against flu in the 1990s, then first tested in humans in 2013 to vaccinate against rabies . It was thanks to these decades of research and testing that mRNA vaccine technology was ready and safe during the COVID-19 pandemic. Kennedy has been a longtime critic of the technology, saying in a video posted to social media platforms that mRNA programs are "troubled'. "We're prioritizing the development of safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don't collapse when viruses mutate," Kennedy said in the video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video There are many types of vaccines in development that have different methods of helping the body to fight a virus. Each technology has advantages and limitations which depend on the disease, the target population, and practical considerations like production speed and costs. Vaccine technology platforms include live (but weakened) and deactivated "whole" pathogen vaccines. The polio vaccine is available in both forms, for example. There are also toxoid-based vaccines, which use inactivated bacterial toxins. Then there are viral vector vaccines, which train the immune system by introducing tiny viral pathogenic fragments into the body. DNA-based therapies are also being considered as another way to provide an accurate target for a human immune response. Luka Cicin-Sain, a viral immunologist at Germany's Helmholtz Centre for Infection Research, is leading the development of a respiratory syncytial virus (RSV) vaccine. The RSV vaccine is a viral vector product, which uses a low-risk mouse virus to deliver the RSV spike protein to the human immune system. Though still being tested, Cicin-Sain is hopeful that his platform will provide long-lasting immunity against RSV with a single immunization dose. Despite the promise these other vaccine technologies have shown, they haven't had the same impact as their mRNA cousin. That's because the benefit of using mRNA technology as vaccines is the ability to quickly adapt their use for new pathogens. "Once you know the structure of the virus, the genetics of the virus, then you can produce a vaccine extremely rapidly," said Penny Ward, a pharmaceutical physician at Kings College London, UK. In some cases, mRNA vaccines can be more effective at training the body's immune response to a pathogen. "We don't seem to produce the same immune response to a DNA vaccine as we have to a [m]RNA vaccine," said Ward. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video There is no guarantee the $500 million funding will flow to other vaccine research. Kennedy is a longtime vaccine critic — he has fired the panel that makes vaccine recommendations and shared anti-vax sentiment, including during a measles outbreak in the US in May. Cicin-Sain worries that defunding one branch of vaccine science hinders overall progress in the research field. "I'm not saying that mRNA vaccines can solve everything, but why deny yourself a tool in your toolkit?" Cicin-Sain said. Kennedy's funding cuts will slow down RNA technology development, Cicin-Sain said, and drive American scientists to compete for funding outside the US, diminishing ongoing vaccine science. While other private and philanthropical research funds do exist to fund mRNA vaccine technologies, it's unlikely they can fill the $500 million gap left by the Trump administration's cuts. There's also no guarantee other national governments will step in to fill the US void. "The funding in Europe has been stagnant," said Cicin-Sain. "And there are not so many [private] investors out there who think that vaccines are the best way to put their VC [venture capital] at work," he added. Ward highlighted another problem with cuts to publicly funded vaccine research — governments who fund vaccine research get first access to successful products, which is why Brits were among the first to get the Oxford-AstraZeneca vaccine. "Government funding secures access for countries that are part funders for those products," Ward told DW. If private funders step in to fund mRNA vaccine research, it could reduce people's access to those vaccines at an affordable price. "If progress is to be made, and there's no source of government funding, the industry will fund [research] if they believe there's a market, but that will be reflected in the price of the eventual product,' Ward said. "No matter how you slice or dice, the net effects are going to be negative," Cicin-Sain said.
